| Article | Date | Source |
|---|
| Newsmaker: Agios Pharmaceuticals | -- | Nature Biotechnology |
| Agios Research in Cancer Metabolism Highlighted at AACR Annual Meeting 2012 | April 03, 2012 | Pharma News - Business Wire |
| Agios Pharmaceuticals to Present at the Cowen and Company 32nd Annual Health Care Conference | February 29, 2012 | Pharma News - Business Wire |
| Agios Pharmaceuticals to Present at the Leerink Swann 2012 Global Healthcare Conference | February 09, 2012 | Pharma News - Business Wire |
| Agios Pharmaceuticals, Inc.: Series C $78M | January 31, 2012 | OnBioVC |
| Agios Pharmaceuticals to Present at 30th Annual J.P. Morgan Healthcare Conference | January 03, 2012 | Pharma News - Business Wire |
| Abramson Family Institute sues Cambridge biotech Agios and co-founder Craig Thompson | December 31, 2011 | Biotechnology - Moreover |
| Aileron Expands Roche Deal, Agios Gets $78M, Genzyme MS Drug Advances, & More Boston-Area Life Sciences News | November 18, 2011 | Xconomy Life Sciences |
| UPDATED: Agios adds $78M C round to back cancer drug portfolio | November 17, 2011 | FierceBiotech |
| Agios Secures $78M to Progress Cancer Metabolism-Targeting Drugs into Clinic | November 17, 2011 | Inside Industry - Gen |
| Agios Pharmaceuticals Secures $78 Million Series C Financing | November 17, 2011 | BioSpace |
| Agios raises $78M series C round for cancer drug trials | November 17, 2011 | Health News - BizJournals.com |
| Boston VC news in brief - Agios raises $78M, Seniorlink raises $5M | November 17, 2011 | Health News - BizJournals.com |
| Agios Nabs $78M From Partner Celgene, Existing VCs, and Public Funds | November 17, 2011 | Xconomy Life Sciences |
| Agios Secures $78 Million in Oversubscribed Series C Financing | November 17, 2011 | Pharma News - Business Wire |
| Agios adds $78M C round to back cancer drug portfolio | November 17, 2011 | FierceBiotech |
| Agios and Celgene: Anatomy of an Ultra-Valuable Biotech Marriage | October 11, 2011 | Xconomy Life Sciences |
| Celgene Pays Agios $20M, Lycera Adds Cambridge CEO, Getinge Buys Atrium Medical, & More Boston-Area Life Sciences News | October 07, 2011 | Xconomy Life Sciences |
| Celgene Corporation Pays $20 Million to Extend Agios Pharmaceuticals Agreement | October 05, 2011 | BioSpace |
| Celgene Pays $20 Million to Extend Agios Pharmaceuticals Agreement | October 05, 2011 | BioSpace |
| Celgene pays Agios $20M to extend cancer drug pact | October 05, 2011 | Health News - CNBC |
| Celgene Pays $20 Million to Extend Agios Pharmaceuticals Agreement?
| October 05, 2011 | BioSpace |
| Agios Pulls in $20M From Celgene, Under Extended Cancer Metabolism Partnership | October 05, 2011 | Xconomy Life Sciences |
| UPDATED: Agios wins $20M haul as Celgene extends cancer development pact | October 05, 2011 | FierceBiotech |
| Cancer upstart Agios wins $20M haul as Celgene extends development pact | October 05, 2011 | FierceBiotech |
| Celgene and Agios Extend Cancer Metabolism Collaboration | October 05, 2011 | Pharma News - Business Wire |
| Marc Tessier-Lavigne, Ph.D., President of The Rockefeller University, Joins Agios Board of Directors | September 20, 2011 | Biotech News - Business Wire |
| Agios Pharmaceuticals Founder and Advisor Publish In On Further Links Between Serine Metabolic Pathway and Cancer | August 02, 2011 | BioSpace - Breaking News |
| Agios Founder and Advisor Publish In Nature Genetics On Further Links Between Serine Metabolic Pathway and Cancer | August 02, 2011 | Pharma News - Business Wire |
| Agios Pharmaceuticals and Whitehead Institute Collaborate on Nature Publication Revealing Altered Metabolic Pathway in Breast Cancer | July 15, 2011 | BioSpace - Breaking News |
| Agios and Whitehead Institute Collaborate on Nature Publication Revealing Altered Metabolic Pathway in Breast Cancer | July 14, 2011 | Biotech News - Business Wire |
| Tripos Announces Agios Pharmaceuticals’ Choice of D360 Software | June 01, 2011 | Pharma News - Business Wire |
| Agios Pharmaceuticals to Present at 31st Annual Cowen Healthcare Conference | March 01, 2011 | Pharma News - Business Wire |
| Agios Pharmaceuticals to Present at 29th Annual J.P. Morgan Healthcare Conference | January 06, 2011 | Pharma News - Business Wire |
| Agios Announces Cancer Cell Publication of Research Illuminating Link between Cancer Metabolism and Epigenetics | December 14, 2010 | Pharma News - Business Wire |
| Agios Pharmaceuticals Awarded Two Federal Grants to Advance Cancer Metabolism Focused Therapeutics | November 05, 2010 | BioSpace - Breaking News |
| Agios Awarded Two Federal Grants to Advance Cancer Metabolism Focused Therapeutics | November 04, 2010 | Inside Industry - Gen |
| Agios Appoints Scott Biller, Ph.D., Industry Leader and Drug Developer, as Chief Scientific Officer | September 20, 2010 | Pharma News - Business Wire |
| Agios boosts staff following Celgene deal | July 29, 2010 | Health News - BizJournals.com |
| Agios Creates Expanded Scientific Advisory Role for Lewis Cantley, Ph.D. | July 29, 2010 | Pharma News - Business Wire |
| Third Rock Invests in Ablexis, Acceleron Grabs $8.4M, Alnylam Chief Joins Agios Board, & More Boston-Area Life Sciences News | June 25, 2010 | Xconomy Life Sciences |
| Agios Adds Alnylam Chief to Board | June 24, 2010 | Xconomy Life Sciences |
| Agios Appoints John Maraganore, Ph.D., to Board of Directors | June 24, 2010 | Pharma News - Business Wire |
| Agios Scientists Present IDH1 Data at 2010 AACR Meeting | April 21, 2010 | Pharma News - Business Wire |
| Oracle Acquires Phase Forward, Diax Collects Up to $12M from Paul Capital, Agios Gets $130M from Celgene, & More Boston-Area Deals News | April 21, 2010 | Xconomy Life Sciences |
| Genzyme Activist Joins Board, Agios Clinches Deal With Celgene, Third Rock Seeks $400M New Fund, & More Boston-Area Life Sciences News | April 16, 2010 | Xconomy Life Sciences |
| Celgene, Privately-held Agios Pharma To Develop Cancer Metabolism Programs - Update | April 15, 2010 | Biotechnology - Moreover |
| Agios Pharma inks $130m partnership | April 15, 2010 | Health News - BizJournals.com |
| Celgene Pays Agios $130M Up Front for Exclusive Options to Therapeutics Targeting Cancer Metabolism | April 15, 2010 | GEN News Highlights |
| Celgene Pumps $130M Upfront into Agios Pharma for Drugs that Starve Cancer Cells | April 15, 2010 | Xconomy Life Sciences |
| Celgene, Agios developing cancer treatments | April 15, 2010 | Health News - CNBC |
| Celgene Corporation et Agios Pharmaceuticals annoncent une collaboration stratégique mondiale pour faire progresser la science unique du métabolisme du cancer | April 15, 2010 | Pharma News - Business Wire |
| Samenvatting: Celgene Corporation en Agios Pharmaceuticals melden internationale strategische samenwerking voor bevordering van kennis van kankermetabolisme | April 15, 2010 | Pharma News - Business Wire |
| Celgene and Agios Pharmaceuticals Announce Global Strategic Collaboration to Advance Unique Science of Cancer Metabolism; Will Receive $130 Million Upfront | April 15, 2010 | BioSpace |
| Agios scores $130M upfront from ambitious Celgene pact | April 15, 2010 | FierceBiotech |
| Celgene Corporation e Agios Pharmaceuticals anunciam colaboração estratégica global para o avanço de pesquisas exclusivas sobre o metabolismo do câncer | April 15, 2010 | Pharma News - Business Wire |
| Celgene Corporation and Agios Pharmaceuticals Announce Global Strategic Collaboration to Advance Unique Science of Cancer Metabolism | April 15, 2010 | Pharma News - Business Wire |
| Riassunto: Celgene Corporation e Agios Pharmaceuticals annunciano cooperazione strategica globale per promuovere una scienza unica del metabolismo del cancro | April 15, 2010 | Pharma News - Business Wire |
| Celgene Corporation y Agios Pharmaceuticals anuncian colaboración estratégica mundial para desarrollar la extraordinaria ciencia del metabolismo del cáncer | April 15, 2010 | Pharma News - Business Wire |
| Celgene Corporation und Agios Pharmaceuticals verkünden globale strategische Zusammenarbeit, um einzigartige Forschungsarbeit über den Stoffwechsel von Krebszellen voranzutreiben | April 15, 2010 | Pharma News - Business Wire |
| Agios Pharmaceuticals Appoints William Kaelin Jr., M.D. to Scientific Advisory Board | March 11, 2010 | Pharma News - Business Wire |
| Agios Pharma lands brain-cancer grant | December 21, 2009 | Health News - BizJournals.com |
| Agios Pharmaceuticals Awarded Funding From Accelerate Brain Cancer Cure (ABC2) to Support Research into Novel Therapeutics and Diagnostics for Brain Cancer | | Pharma News - Business Wire |
